EOLS
Price
$9.72
Change
+$0.06 (+0.62%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
846.82M
20 days until earnings call
TAK
Price
$14.82
Change
-$0.31 (-2.05%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
43.11B
20 days until earnings call
Interact to see
Advertisement

EOLS vs TAK

Header iconEOLS vs TAK Comparison
Open Charts EOLS vs TAKBanner chart's image
Evolus
Price$9.72
Change+$0.06 (+0.62%)
Volume$17.06K
Capitalization846.82M
Takeda Pharmaceutical
Price$14.82
Change-$0.31 (-2.05%)
Volume$32.45K
Capitalization43.11B
EOLS vs TAK Comparison Chart in %
Loading...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EOLS vs. TAK commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EOLS is a StrongBuy and TAK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (EOLS: $9.66 vs. TAK: $15.13)
Brand notoriety: EOLS and TAK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EOLS: 84% vs. TAK: 77%
Market capitalization -- EOLS: $846.82M vs. TAK: $43.11B
EOLS [@Pharmaceuticals: Other] is valued at $846.82M. TAK’s [@Pharmaceuticals: Other] market capitalization is $43.11B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EOLS’s FA Score shows that 0 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • EOLS’s FA Score: 0 green, 5 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, TAK is a better buy in the long-term than EOLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EOLS’s TA Score shows that 4 TA indicator(s) are bullish while TAK’s TA Score has 5 bullish TA indicator(s).

  • EOLS’s TA Score: 4 bullish, 3 bearish.
  • TAK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, EOLS is a better buy in the short-term than TAK.

Price Growth

EOLS (@Pharmaceuticals: Other) experienced а +4.89% price change this week, while TAK (@Pharmaceuticals: Other) price change was -1.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +55.51%. For the same industry, the average monthly price growth was +85.18%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

EOLS is expected to report earnings on Nov 11, 2025.

TAK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+55.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($43.1B) has a higher market cap than EOLS($847M). TAK YTD gains are higher at: 14.275 vs. EOLS (-12.500). TAK has higher annual earnings (EBITDA): 1.01T vs. EOLS (-41.81M). TAK has more cash in the bank: 317B vs. EOLS (62.8M). EOLS has less debt than TAK: EOLS (127M) vs TAK (4.66T). TAK has higher revenues than EOLS: TAK (4.17T) vs EOLS (202M).
EOLSTAKEOLS / TAK
Capitalization847M43.1B2%
EBITDA-41.81M1.01T-0%
Gain YTD-12.50014.275-88%
P/E RatioN/A36.79-
Revenue202M4.17T0%
Total Cash62.8M317B0%
Total Debt127M4.66T0%
FUNDAMENTALS RATINGS
EOLS vs TAK: Fundamental Ratings
EOLS
TAK
OUTLOOK RATING
1..100
1158
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
10084
PRICE GROWTH RATING
1..100
8152
P/E GROWTH RATING
1..100
10018
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (10) in the Pharmaceuticals Major industry is significantly better than the same rating for EOLS (88). This means that TAK’s stock grew significantly faster than EOLS’s over the last 12 months.

EOLS's Profit vs Risk Rating (67) in the Pharmaceuticals Major industry is somewhat better than the same rating for TAK (100). This means that EOLS’s stock grew somewhat faster than TAK’s over the last 12 months.

TAK's SMR Rating (84) in the Pharmaceuticals Major industry is in the same range as EOLS (100). This means that TAK’s stock grew similarly to EOLS’s over the last 12 months.

TAK's Price Growth Rating (52) in the Pharmaceuticals Major industry is in the same range as EOLS (81). This means that TAK’s stock grew similarly to EOLS’s over the last 12 months.

TAK's P/E Growth Rating (18) in the Pharmaceuticals Major industry is significantly better than the same rating for EOLS (100). This means that TAK’s stock grew significantly faster than EOLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EOLSTAK
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
40%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
37%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 11 days ago
43%
Declines
ODDS (%)
Bearish Trend 28 days ago
80%
Bearish Trend 3 days ago
44%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
37%
View a ticker or compare two or three
Interact to see
Advertisement
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BEGS29.991.08
+3.73%
Rareview 2X Bull Cryptoccy & Prc Mtl ETF
FYC80.691.11
+1.39%
First Trust Small Cap Gr AlphaDEX® ETF
TPHE25.660.04
+0.17%
Timothy Plan High Dividend Stock Enh ETF
TDIV92.100.15
+0.16%
First Trust NASDAQ Technology Div ETF
GGZ13.50N/A
N/A
Gabelli Global Small and Mid Cap Value Trust (The)

EOLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EOLS has been loosely correlated with AMRX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EOLS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
+4.32%
AMRX - EOLS
33%
Loosely correlated
+0.97%
ALKS - EOLS
31%
Poorly correlated
+2.04%
NBIX - EOLS
30%
Poorly correlated
+3.71%
AQST - EOLS
30%
Poorly correlated
+8.97%
PRGO - EOLS
28%
Poorly correlated
+0.29%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with SGIOY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then SGIOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
+0.73%
SGIOY - TAK
41%
Loosely correlated
+1.53%
HLN - TAK
37%
Loosely correlated
N/A
ESAIY - TAK
35%
Loosely correlated
+1.47%
BNXTF - TAK
32%
Poorly correlated
+9.97%
EOLS - TAK
27%
Poorly correlated
+4.32%
More